Molecules and Cells

Cited by CrossRef (18)

  1. Holly Lee, Peter Duggan, Ahsan Chaudhry, Paola Neri, Jason Tay, Fariborz Rashid-Kolvear, Nizar J. Bahlis, Victor H. Jimenez-Zepeda. Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia 2018;18:e69
    https://doi.org/10.1016/j.clml.2017.10.009
  2. Tomalika Rahmat Ullah. The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond. Journal of Bone Oncology 2019;17:100253
    https://doi.org/10.1016/j.jbo.2019.100253
  3. Elisa Cocco, Manuela Leo, Claudia Canzonetta, Serena Di Vito, Antonello Mai, Dante Rotili, Arianna Di Napoli, Andrea Vecchione, Cosimo De Nunzio, Patrizia Filetici, Antonella Stoppacciaro. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2. Clin Epigenet 2018;10
    https://doi.org/10.1186/s13148-018-0473-4
  4. Miao Li, Lin Qi, Jing-Bo Xu, Li-Ye Zhong, Szehoi Chan, Shu-Na Chen, Xin-Rong Shao, Li-Yuan Zheng, Zhao-Xia Dong, Tian-Liang Fang, Zhi-Ying Mai, Juan Li, Yongjiang Zheng, Xing-Ding Zhang. Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma. Molecular Therapy - Oncolytics 2020;19:197
    https://doi.org/10.1016/j.omto.2020.10.004
  5. Thomas R. Cox, Janine T. Erler, Robin M. H. Rumney. Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease. Calcif Tissue Int 2018;102:163
    https://doi.org/10.1007/s00223-017-0352-6
  6. Rofaida Gaballa, Hamdy E. A. Ali, Mohamed O. Mahmoud, Johng S. Rhim, Hamed I. Ali, Heba F. Salem, Mohammad Saleem, Mohamed A. Kandeil, Stefan Ambs, Zakaria Y. Abd Elmageed. Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition. Cancers 2020;12:2300
    https://doi.org/10.3390/cancers12082300
  7. Alday-Parejo, Stupp, Rüegg. Are Integrins Still Practicable Targets for Anti-Cancer Therapy?. Cancers 2019;11:978
    https://doi.org/10.3390/cancers11070978
  8. Jun-Fu Wang, Ye Wang, Si-Wen Zhang, Ye-Yang Chen, Yue Qiu, Shao-Yi Duan, Bo-Pei Li, Jun-Qiang Chen, Nihal Ahmad. Expression and Prognostic Analysis of Integrins in Gastric Cancer. Journal of Oncology 2020;2020:1
    https://doi.org/10.1155/2020/8862228
  9. Seungjun Ahn, Tyler Grimes, Somnath Datta. The Analysis of Gene Expression Data Incorporating Tumor Purity Information. Front. Genet. 2021;12
    https://doi.org/10.3389/fgene.2021.642759
  10. Anastazja Poczta, Aneta Rogalska, Agnieszka Marczak. Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches. JCM 2021;10:1841
    https://doi.org/10.3390/jcm10091841
  11. Shusen Zhang, Dengxiang Liu, Xuecong Ning, Xiaochong Zhang, Yuanyuan Lu, Yang Zhang, Aimin Li, Zhiguo Gao, Zhihua Wang, Xiaoling Zhao, Shubo Chen , Zhigang Cai. A Signature Constructed Based on the Integrin Family Predicts Prognosis and Correlates with the Tumor Microenvironment of Patients with Lung Adenocarcinoma . J Environ Pathol Toxicol Oncol 2023;42:59
    https://doi.org/10.1615/JEnvironPatholToxicolOncol.2022046232
  12. Xuanguang Li, Guangsheng Zhu, Yongwen Li, Hua Huang, Chen Chen, Di Wu, Peijun Cao, Ruifeng Shi, Lianchun Su, Ruihao Zhang, Hongyu Liu, Jun Chen. LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma. Front. Immunol. 2023;14
    https://doi.org/10.3389/fimmu.2023.1096818
  13. Taro Ayabe, Masaharu Hisasue, Yoko Yamada, Suguru Nitta, Kaoruko Kikuchi, Sakurako Neo, Yuki Matsumoto, Ryo Horie, Kosuke Kawamoto. Characterisation of canine CD34+/CD45 diminished cells by colony-forming unit assay and transcriptome analysis. Front. Vet. Sci. 2022;9
    https://doi.org/10.3389/fvets.2022.936623
  14. Yu Huang, Dong-Ming Guo, Shi Bu, Wei Xu, Qing-Chun Cai, Jian Xu, Yue-Quan Jiang, Fei Teng. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers. Adv Ther 2023
    https://doi.org/10.1007/s12325-023-02469-2
  15. Yun Zhao, Xiaoxia Peng, Hope Baldwin, Chao Zhang, Zhongmin Liu, Xin Lu. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021;1867:166151
    https://doi.org/10.1016/j.bbadis.2021.166151
  16. Anna V. Komina, Nadezhda V. Palkina, Mariya B. Aksenenko, Semyon N. Lavrentev, Anton V. Moshev, Andrey A. Savchenko, Anton S. Averchuk, Yuri A. Rybnikov, Tatiana G. Ruksha. Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status. 2019;29:544
    https://doi.org/10.1097/CMR.0000000000000621
  17. Eva Bianconi, Raffaella Casadei, Flavia Frabetti, Carlo Ventura, Federica Facchin, Silvia Canaider. Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells. Genes 2020;11:909
    https://doi.org/10.3390/genes11080909
  18. AmalA Elsharif, LaurenceH Patterson, StevenD Shnyder, HelenM Sheldrake. The role of integrins in acute leukemias and potential as targets for therapy. Tumor Microenviron 2018;1:63
    https://doi.org/10.4103/tme.tme_4_19